author-photo

Patrick G. Pollard

Merck & Co.

5

Papers

95

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist.

2011 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (13)
Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist

2005 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (40)